Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
35.93
+1.13 (3.25%)
At close: Sep 8, 2025, 4:00 PM
36.99
+1.06 (2.95%)
After-hours: Sep 8, 2025, 7:05 PM EDT
Mineralys Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts that cover Mineralys Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $33.75, which forecasts a -6.07% decrease in the stock price over the next year. The lowest target is $24 and the highest is $43.
Price Target: $33.75 (-6.07%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mineralys Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +16.89% | Sep 8, 2025 |
| Jefferies | Jefferies | Hold Maintains $15 → $26 | Hold | Maintains | $15 → $26 | -27.64% | Sep 3, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $38 → $43 | Strong Buy | Maintains | $38 → $43 | +19.68% | Aug 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +16.89% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +16.89% | Jun 17, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.74
from -3.66
EPS Next Year
-2.83
from -2.74
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.53 | -2.22 | |||
| Avg | -2.74 | -2.83 | |||
| Low | -2.95 | -3.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.